Commentary & Perspectives
Clinicians Warn of Fatal Measles Brain Disease
-
By
-
March 13, 2026
-
4 min
By
March 13, 2026
Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.
March 13, 2026
ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness
March 12, 2026
What earlier mNGS testing could mean for labs and clinicians
March 12, 2026